Pacific Biosciences Of California PACB
NASDAQ PACB
$2.41 +0.58 (+31.97%)
As of: Sep 30, 2026 · 11:37 AM EDT

Pacific Biosciences Of California (PACB) Receivables - Other (2011 - 2013)

Updated

Pacific Biosciences Of California (PACB) posted Receivables - Other of $3,000 for Q4 2013, down 99.6% from $814,000 a year earlier.

Analysis

Pacific Biosciences Of California (PACB) Receivables - Other (2011 - 2013) Analysis & Trends

  • In prior years, Pacific Biosciences Of California's Receivables - Other was $814,000 in FY2012 and $17,000 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Pacific Biosciences Of California 531.49 Mn -559.51 Mn 12.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 3,000.00
Dec 31, 2012 814,000.00
Dec 31, 2011 17,000.00
API Access

Pacific Biosciences Of California Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=PACB&period=max&api_key=YOUR_API_KEY